Stockscreener 앱 받기
3.34
6.03%
0.19
Achieve Life Sciences Inc 주식(ACHV)의 최신 뉴스
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Purchased by Northern Trust Corp - Defense World
Shay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
ACHV: New Insights from ORCA-3 Study to Be Shared at 2025 Conference | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present Phase 3 Study Findings on Cytisinicline for Smoking Cessation at 2025 ATS Conference - Nasdaq
Achieve Life Sciences to Present New Data at the 2025 ATS - GlobeNewswire
New Clinical Data Shows Cytisinicline Cuts Nicotine Cravings in Phase 3 Trial | ACHV Stock News - Stock Titan
Brokers Offer Predictions for ACHV Q3 Earnings - Defense World
Tower Research Capital LLC TRC Acquires 4,905 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
What is Zacks Small Cap’s Estimate for ACHV Q2 Earnings? - Defense World
Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones - MSN
Raymond James Financial Inc. Purchases New Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call Transcript - Insider Monkey
ACHV: Kicking Butts to Achieve June NDA Filing - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Earnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence market - Investing.com Nigeria
Earnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence market By Investing.com - Investing.com South Africa
Transcript : Achieve Life Sciences, Inc., Q1 2025 Earnings Call, May 13, 2025 - marketscreener.com
ACHV Prepares for FDA Submission of New Smoking Cessation Drug | - GuruFocus
Achieve Life Sciences Inc Reports Q1 2025 EPS of -$0.37, Aligns with Estimates; Revenue Remains at $0 Million - GuruFocus
ACHIEVE LIFE SCIENCES Earnings Results: $ACHV Reports Quarterly Earnings - Nasdaq
Achieve Life Sciences Reports First Quarter 2025 Financial Resul - GuruFocus
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program - The Manila Times
Achieve Life Sciences Inc. Q1 Loss Increases In Line With Estimates - Nasdaq
ACHIEVE LIFE SCIENCES, INC. SEC 10-Q Report - TradingView
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Bought by Barclays PLC - Defense World
Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Wells Fargo & Company MN Boosts Holdings in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Renaissance Technologies LLC Increases Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Achieve Life Sciences (ACHV) to Release Quarterly Earnings on Thursday - MarketBeat
Will Cytisinicline Achieve The Long-Awaited Breakthrough In Nicotine Addiction Treatment? - RTTNews
Achieve Life Sciences to Announce First Quarter 2025 Financial R - GuruFocus
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 | ACHV Stock News - GuruFocus
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 - The Manila Times
Achieve Life Sciences to Announce First Quarter 2025 - GlobeNewswire
Achieve Life Sciences to Report Q1 Earnings: Latest Updates on Smoking Cessation Drug Development - Stock Titan
Achieve Life Sciences Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Buys 44,311 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Will the FDA approve the first new drug to help people quit smoking in 20 years? - statnews.com
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Stock Position Boosted by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) - MSN
LPL Financial LLC Has $693,000 Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
LPL Financial LLC Acquires 5,500 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - The AM Reporter
Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial - Yahoo Finance
Cytisinicline shows promise for smoking cessation By Investing.com - Investing.com Canada
0.95%
자본화:
|
볼륨(24시간):